SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO) is trending as investors weigh its long-term potential in decentralized AI against recent volatility fueled by subnet departures and governance concerns. Community members remain deeply divided, with many taking advantage of the dip to accumulate, while others express caution over centralization risks and the project's ability to maintain its competitive edge.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is facing intense market volatility as investors weigh the competitive threat of new multiple myeloma combination therapies against the company's strong commercial growth and profitable CAR-T pipeline. While analysts remain bullish on its long-term potential and pipeline value, the community is actively debating whether current price levels represent a significant accumulation opportunity or a signal of deeper structural concerns regarding institutional sentiment and management's independence.

Sony Group Corp. engages in the development, design, manufacture, and sale of electronic equipment, instruments, devices, game consoles, and software for consumers, professionals and industrial markets. It operates through the following segments: Game and Network Services, Music, Pictures, Entertainment Technology & Services, Imaging and Sensing Solutions, Financial Services, and Others. The Game and Network Services segment deals with gaming machines, software and network services. The Music segment produces and publishes music and provides image media platforms. The Pictures segment handles film production, television program creation, and media networks. The Home Entertainment and Sound segment offers LCD televisions, home audio, Blu-ray Disc players and recorders, and memory-based portable audio devices. The Imaging and Sensing Solutions segment includes the image sensors business. The Financial Services segment manages the life insurance and non-life insurance operations and banking business. The Others segment consists of various operating activities, including the disc manufacturing and recording media businesses. The company was founded by Akio Morita and Masaru Ibuka on May 7, 1946 and is headquartered in Tokyo, Japan.

Sony Group Corporation - ADR

Sony Group Corporation

Sony is trending as the market reacts to the company's decision to discontinue physical disc production by 2028, a move sparking widespread community backlash and debates over the future of digital ownership. Investors are also closely monitoring the stock as a potential long-term play on edge AI infrastructure, fueled by its dominant market share in CMOS image sensors and strategic shifts in its entertainment divisions.

BNB is the native utility token of the BNB Chain ecosystem, acting as a multi-chain asset that powers decentralized applications and facilitates value exchange across its network. It serves as the primary asset for paying transaction gas and smart contract deployment fees while providing users with tiered fee discounts on the Binance exchange. The project’s main value proposition lies in its unified multi-chain architecture, which integrates a smart contract platform, a Layer 2 scaling solution, and a decentralized data storage network into a cohesive settlement and data availability layer.  The network operates on a Proof of Staked Authority consensus mechanism, utilizing a group of 21 active validators known as the Cabinet to verify transactions and produce blocks every 3 seconds. Validators are elected daily based on the amount of BNB staked or delegated to them, and the system employs fast finality and slashing penalties to maintain security and integrity. To manage its long-term economy, the project uses a programmatic dual-burn strategy that permanently removes tokens through real-time fee destruction and quarterly buybacks.  Launched in 2017 by the Binance platform, the project initially distributed 50% of its 200 million token supply to the public, while the founding team received 40% and angel investors were allocated 10%. Though it began as a token on the Ethereum network, it eventually migrated to its own autonomous architecture that remains fully compatible with the Ethereum Virtual Machine. Today, the token's utility includes paying for network gas, participating in staking rewards, and enabling decentralized governance through which holders can vote on technical upgrades and economic changes.

Binance

Binance is trending as the community debates updates to its VIP Program, including revised asset thresholds and spot trading volume multipliers, alongside ongoing discussions about its evolving role in AI infrastructure. Investors are closely monitoring price action near key support levels while tracking the integration of real-world asset (RWA) tokenization and institutional financing tools across the ecosystem.

Lighter is a decentralized trading platform built for unmatched security and scale. It’s the first exchange to offer verifiable order matching and liquidations while delivering best-in-class performance on par with traditional exchanges.

lighter

Lighter is trending as the protocol gains momentum through its integration with Robinhood and a strategic tokenomics overhaul, featuring significant revenue-funded token burns. Community members are actively debating its potential as a competitor to established perpetual DEXs, closely watching key technical levels while tracking whale activity and volume surges.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Aerodrome Finance is gaining traction as investors speculate on a major upcoming token merger and expansion to the Ethereum mainnet, viewing it as a cornerstone liquidity hub for the Base ecosystem. While some users are actively accumulating during price fluctuations, community discussion remains divided between long-term bulls betting on its protocol-driven revenue and bears cautioning against potential volatility.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistra Corp is trending as investors aggressively position themselves for the accelerating AI infrastructure buildout, viewing the company's significant nuclear and grid capacity as a critical bottleneck solution for massive data center power demand. While some community members express frustration with recent price consolidation and volatility, the broader sentiment remains fixated on long-term institutional buying and the company's strategic alignment with hyperscaler energy needs.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is seeing significant retail volatility following a quarterly report that showed a substantial decline in legacy procurement revenue despite strong growth in its high-margin AI systems integration business. The community is actively debating the company's reliance on Dell, with bulls pointing to new facility expansions and key executive hires as signs of long-term scaling, while bears express frustration over management's lack of PR and stagnant revenue growth compared to broader industry trends.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is currently attracting significant attention following an investigative report that exposed its CMO as a fugitive, leading to a temporary decline in share price that many community members are viewing as an attractive buying opportunity. While investors are expressing concerns over corporate governance, the broader sentiment remains strongly focused on the stock's fundamental clinical potential and the possibility of a near-term buyout.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is generating significant investor buzz due to robust growth in its backlog and record order flow, which the community views as essential for supporting the rapidly expanding AI data center infrastructure. While some investors are concerned about share supply dynamics following recent secondary offerings, many are actively accumulating shares on pullbacks, betting that the company's critical role in solving electrical grid bottlenecks will drive long-term value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MMSI vs. WST: Which Stock Should Value Investors Buy Now?

MMSI vs. WST: Which Stock Is the Better Value Option?

Here's Why Merit Medical (MMSI) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Merit Medical (MMSI) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

MMSI's portfolio, acquisitions, R&D strategy and WRAPSODY upside support growth, though tariffs, China pressure and OEM headwinds persist.

MMSI or WST: Which Is the Better Value Stock Right Now?

Why Merit Medical (MMSI) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term

Is the Options Market Predicting a Spike in Merit Medical Systems Stock?

Investors need to pay close attention to MMSI stock based on the movements in the options market lately.

Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now

MMSI leans on therapeutic strength, an oncology acquisition and a new stent launch, but tariffs, OEM weakness and China pressure shadow 2026.

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Merit Medical Systems, Inc.

Merit Medical Stock Soars After Hours As Better-Than-Expected Q2 Guidance Outweighs CEO Exit

Equity

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.96	--	--	N/A
Q1 '26	$0.83	$0.94	12.85%	BEAT
Q4 '25	$0.95	$1.04	8.98%	BEAT
Q3 '25	$0.83	$0.92	11.14%	BEAT
Q2 '25	$0.85	$1.01	18.73%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

MMSIMerit Medical Systems, Inc.

Upcoming Earnings: Q2 '26

Historical Earnings

Latest MMSI News